EL
Elutia Inc. (ELUT)
NASDAQ·Healthcare·Biotechnology
$1.00
-1.96%
Mkt Cap $49.96M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 11, 2026 | $3.30M | $3.27M | -0.88% | -$0.14 | -$0.14 | +0.00% | — | — |
| Q4 2025 Nov 6, 2025 | $3.30M | $3.32M | +0.70% | -$0.15 | -$0.01 | +93.55% | — | — |
| Q3 2025 Aug 14, 2025 | $7.40M | $6.26M | -15.36% | -$0.17 | -$0.26 | -52.94% | — | — |
| Q2 2025 May 8, 2025 | $6.65M | $6.03M | -9.32% | -$0.20 | -$0.21 | -5.00% | — | — |
| Q1 2025 Mar 6, 2025 | $5.90M | $5.47M | -7.32% | -$0.25 | -$0.26 | -4.00% | — | — |
| Q4 2024 Nov 14, 2024 | $6.40M | $5.92M | -7.47% | -$0.44 | -$0.33 | +25.00% | — | — |
| Q3 2024 Aug 7, 2024 | $6.65M | $6.29M | -5.40% | -$0.33 | -$1.14 | -245.45% | — | — |
| Q2 2024 May 9, 2024 | $6.10M | $6.69M | +9.74% | -$0.41 | -$0.75 | -82.93% | — | — |
| Q1 2024 Mar 7, 2024 | $6.55M | $5.88M | -10.31% | -$0.28 | -$0.66 | -135.71% | — | — |
| Q4 2023 Nov 13, 2023 | $7.30M | $6.13M | -16.07% | -$0.53 | -$0.50 | +5.66% | — | — |
| Q3 2023 Aug 14, 2023 | $12.50M | $10.30M | -17.63% | -$0.29 | -$0.65 | -124.14% | — | — |
| Q2 2023 May 10, 2023 | $13.70M | $13.05M | -4.74% | -$0.54 | -$0.49 | +9.26% | — | — |
| Q1 2023 Mar 22, 2023 | $12.55M | $12.66M | +0.92% | -$0.69 | -$0.38 | +44.93% | — | — |
| Q3 2022 Sep 29, 2022 | $12.38M | $12.39M | +0.09% | -$0.67 | -$0.73 | -9.09% | — | — |
| Q2 2022 Jun 29, 2022 | — | $12.64M | — | — | -$0.69 | — | — | — |
| Q1 2022 Mar 30, 2022 | $11.59M | $11.49M | -0.78% | -$0.56 | -$0.60 | -7.68% | — | — |
| Q4 2021 Dec 30, 2021 | — | $10.86M | — | — | -$0.82 | — | — | — |
| Q3 2021 Sep 29, 2021 | — | $11.48M | — | — | -$0.81 | — | — | — |